Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 99

1.

Application of glycoproteomics for the discovery of biomarkers in lung cancer.

Li QK, Gabrielson E, Zhang H.

Proteomics Clin Appl. 2012 Jun;6(5-6):244-56. doi: 10.1002/prca.201100042. Review.

2.

Glycoproteomics using fluid-based specimens in the discovery of lung cancer protein biomarkers: promise and challenge.

Li QK, Gabrielson E, Askin F, Chan DW, Zhang H.

Proteomics Clin Appl. 2013 Jan;7(1-2):55-69. doi: 10.1002/prca.201200105. Review.

3.

Large-scale identification of secretome glycoproteins recognized by Wisteria floribunda agglutinin: A glycoproteomic approach to biomarker discovery.

Sugahara D, Tomioka A, Sato T, Narimatsu H, Kaji H.

Proteomics. 2015 Sep;15(17):2921-33. doi: 10.1002/pmic.201400443. Epub 2015 Jun 11.

PMID:
25921242
4.

[Research Progress of Biomakers Proteomics-based in Lung Cancer].

Xie H, Chen Z, Wang G.

Zhongguo Fei Ai Za Zhi. 2015 Jun;18(6):391-6. doi: 10.3779/j.issn.1009-3419.2015.06.11. Review. Chinese.

5.

Glycoproteomics and clinical applications.

Tian Y, Zhang H.

Proteomics Clin Appl. 2010 Feb;4(2):124-32. doi: 10.1002/prca.200900161. Epub 2009 Dec 9. Review.

PMID:
21137038
6.

Biomarkers and molecular testing for early detection, diagnosis, and therapeutic prediction of lung cancer.

Pass HI, Beer DG, Joseph S, Massion P.

Thorac Surg Clin. 2013 May;23(2):211-24. doi: 10.1016/j.thorsurg.2013.01.002. Epub 2013 Feb 15. Review.

PMID:
23566973
7.

Mass spectrometry based glycoproteomics--from a proteomics perspective.

Pan S, Chen R, Aebersold R, Brentnall TA.

Mol Cell Proteomics. 2011 Jan;10(1):R110.003251. doi: 10.1074/mcp.R110.003251. Epub 2010 Aug 24. Review.

8.

Glycoproteomic analysis of WGA-bound glycoprotein biomarkers in sera from patients with lung adenocarcinoma.

Hongsachart P, Huang-Liu R, Sinchaikul S, Pan FM, Phutrakul S, Chuang YM, Yu CJ, Chen ST.

Electrophoresis. 2009 Apr;30(7):1206-20. doi: 10.1002/elps.200800405.

PMID:
19294700
9.

The state of molecular biomarkers for the early detection of lung cancer.

Hassanein M, Callison JC, Callaway-Lane C, Aldrich MC, Grogan EL, Massion PP.

Cancer Prev Res (Phila). 2012 Aug;5(8):992-1006. doi: 10.1158/1940-6207.CAPR-11-0441. Epub 2012 Jun 11. Review.

10.

Integrative proteomics and tissue microarray profiling indicate the association between overexpressed serum proteins and non-small cell lung cancer.

Liu Y, Luo X, Hu H, Wang R, Sun Y, Zeng R, Chen H.

PLoS One. 2012;7(12):e51748. doi: 10.1371/journal.pone.0051748. Epub 2012 Dec 19.

11.

Biomarkers for the lung cancer diagnosis and their advances in proteomics.

Sung HJ, Cho JY.

BMB Rep. 2008 Sep 30;41(9):615-25. Review.

12.

Proteomic approaches in lung cancer biomarker development.

Cho JY, Sung HJ.

Expert Rev Proteomics. 2009 Feb;6(1):27-42. doi: 10.1586/14789450.6.1.27. Review.

PMID:
19210125
13.

Discovery of potential protein biomarkers of lung adenocarcinoma in bronchoalveolar lavage fluid by SWATH MS data-independent acquisition and targeted data extraction.

Ortea I, Rodríguez-Ariza A, Chicano-Gálvez E, Arenas Vacas MS, Jurado Gámez B.

J Proteomics. 2016 Apr 14;138:106-14. doi: 10.1016/j.jprot.2016.02.010. Epub 2016 Feb 18.

PMID:
26917472
14.

Label-free quantitative proteomics and N-glycoproteomics analysis of KRAS-activated human bronchial epithelial cells.

Sudhir PR, Chen CH, Pavana Kumari M, Wang MJ, Tsou CC, Sung TY, Chen JY, Chen CH.

Mol Cell Proteomics. 2012 Oct;11(10):901-15. Epub 2012 Jul 3.

15.

Identification of urine protein biomarkers with the potential for early detection of lung cancer.

Zhang H, Cao J, Li L, Liu Y, Zhao H, Li N, Li B, Zhang A, Huang H, Chen S, Dong M, Yu L, Zhang J, Chen L.

Sci Rep. 2015 Jul 2;5:11805. doi: 10.1038/srep11805.

16.

Analysis of glycoproteins for biomarker discovery.

He J, Liu Y, Wu J, Lubman DM.

Methods Mol Biol. 2013;1002:115-22. doi: 10.1007/978-1-62703-360-2_10.

17.

A robust tool for discriminative analysis and feature selection in paired samples impacts the identification of the genes essential for reprogramming lung tissue to adenocarcinoma.

Toh SH, Prathipati P, Motakis E, Kwoh CK, Yenamandra SP, Kuznetsov VA.

BMC Genomics. 2011 Nov 30;12 Suppl 3:S24. doi: 10.1186/1471-2164-12-S3-S24. Epub 2011 Nov 30.

18.

Lung cancer proteomics, clinical and technological considerations.

Lehtiö J, De Petris L.

J Proteomics. 2010 Sep 10;73(10):1851-63. doi: 10.1016/j.jprot.2010.05.015. Epub 2010 Jun 1. Review.

PMID:
20685322
19.

Unlocking biomarker discovery: large scale application of aptamer proteomic technology for early detection of lung cancer.

Ostroff RM, Bigbee WL, Franklin W, Gold L, Mehan M, Miller YE, Pass HI, Rom WN, Siegfried JM, Stewart A, Walker JJ, Weissfeld JL, Williams S, Zichi D, Brody EN.

PLoS One. 2010 Dec 7;5(12):e15003. doi: 10.1371/journal.pone.0015003.

20.

Molecular sputum analysis for the diagnosis of lung cancer.

Hubers AJ, Prinsen CF, Sozzi G, Witte BI, Thunnissen E.

Br J Cancer. 2013 Aug 6;109(3):530-7. doi: 10.1038/bjc.2013.393. Epub 2013 Jul 18. Review.

Supplemental Content

Support Center